<page><title>Paroxysmal extreme pain disorder</title><url>https://medlineplus.gov/genetics/condition/paroxysmal-extreme-pain-disorder</url><content>Paroxysmal extreme pain disorder
To use the sharing features on this page, please enable JavaScript.
Description
Paroxysmal extreme pain disorder is a condition characterized by skin redness and warmth (flushing) and attacks of severe pain in various parts of the body. The area of flushing typically corresponds to the site of the pain. The pain attacks experienced by people with paroxysmal extreme pain disorder usually last seconds to minutes, but in some cases can last hours. These attacks can start as early as infancy. Early in life, the pain is typically concentrated in the lower part of the body, especially around the rectum, and is usually triggered by a bowel movement. Some children may develop constipation, which is thought to be due to fear of triggering a pain attack. Pain attacks in these young children may also be accompanied by seizures, slow heartbeat, or short pauses in breathing (apnea).
As a person with paroxysmal extreme pain disorder ages, the location of pain changes. Pain attacks switch from affecting the lower body to affecting the head and face, especially the eyes and jaw. Triggers of these pain attacks include changes in temperature (such as a cold wind) and emotional distress as well as eating spicy foods and drinking cold drinks.
Paroxysmal extreme pain disorder is considered a form of peripheral neuropathy because it affects the peripheral nervous system, which connects the brain and spinal cord to muscles and to cells that detect sensations such as touch, smell, and pain.
Frequency
Paroxysmal extreme pain disorder is a rare condition; approximately 80 affected individuals have been described in the scientific literature.
Causes
Mutations in the
SCN9A
gene cause paroxysmal extreme pain disorder. The
SCN9A
gene provides instructions for making one part (the alpha subunit) of a sodium channel called NaV1.7.
Sodium channels
transport positively charged sodium atoms (sodium ions) into cells and play a key role in a cell's ability to generate and transmit electrical signals. NaV1.7 sodium channels are found in nerve cells called nociceptors that transmit pain signals to the spinal cord and brain.
The
SCN9A
gene mutations that cause paroxysmal extreme pain disorder result in NaV1.7 sodium channels that do not close completely when it is turned off, allowing sodium ions to flow abnormally into nociceptors. This increase in sodium ions enhances transmission of pain signals, leading to the pain attacks experienced by people with paroxysmal extreme pain disorder. It is unknown why the pain attacks associated with this condition change location over time or what causes the other features of this condition such as seizures and changes in breathing.
Learn more about the gene associated with Paroxysmal extreme pain disorder
SCN9A
Inheritance
This condition is inherited in an
autosomal dominant pattern
, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Other Names for This Condition
Familial rectal pain
PEPD
PEXPD
Submandibular, ocular, and rectal pain with flushing
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Paroxysmal extreme pain disorder
Genetic and Rare Diseases Information Center
Paroxysmal extreme pain disorder
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Catalog of Genes and Diseases from OMIM
PAROXYSMAL EXTREME PAIN DISORDER; PEXPD
Scientific Articles on PubMed
PubMed
References
Dabby R. Pain disorders and erythromelalgia caused by voltage-gated sodium
channel mutations. Curr Neurol Neurosci Rep. 2012 Feb;12(1):76-83. doi:
10.1007/s11910-011-0233-8.
Citation on PubMed
Estacion M, Han C, Choi JS, Hoeijmakers JG, Lauria G, Drenth JP, Gerrits MM,
Dib-Hajj SD, Faber CG, Merkies IS, Waxman SG. Intra- and interfamily phenotypic
diversity in pain syndromes associated with a gain-of-function variant of NaV1.7.
Mol Pain. 2011 Dec 2;7:92. doi: 10.1186/1744-8069-7-92.
Citation on PubMed
or
Free article on PubMed Central
Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman
J, Klugbauer N, Wood JN, Gardiner RM, Rees M. SCN9A mutations in paroxysmal
extreme pain disorder: allelic variants underlie distinct channel defects and
phenotypes. Neuron. 2006 Dec 7;52(5):767-74. doi: 10.1016/j.neuron.2006.10.006.
Citation on PubMed
Fertleman CR, Ferrie CD, Aicardi J, Bednarek NA, Eeg-Olofsson O, Elmslie FV,
Griesemer DA, Goutieres F, Kirkpatrick M, Malmros IN, Pollitzer M, Rossiter M,
Roulet-Perez E, Schubert R, Smith VV, Testard H, Wong V, Stephenson JB.
Paroxysmal extreme pain disorder (previously familial rectal pain syndrome).
Neurology. 2007 Aug 7;69(6):586-95. doi: 10.1212/01.wnl.0000268065.16865.5f.
Citation on PubMed
Fischer TZ, Waxman SG. Familial pain syndromes from mutations of the NaV1.7
sodium channel. Ann N Y Acad Sci. 2010 Jan;1184:196-207. doi:
10.1111/j.1749-6632.2009.05110.x.
Citation on PubMed
Lampert A, O'Reilly AO, Reeh P, Leffler A. Sodium channelopathies and pain.
Pflugers Arch. 2010 Jul;460(2):249-63. doi: 10.1007/s00424-009-0779-3. Epub 2010
Jan 26.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>